The surgeons may mentally get ready and practice the whole procedure. In addition, the use of this technology should enable the prediction and prevention of future problems. If there are any issues with the program, alternate surgical plans may also be used. The pre-operative surgery planning software market has been predicted to increase at a notable rate in the near future as a result of these cutting-edge and user-friendly capabilities.
Due to increased disposable income, there has been an increase in the use of the pre-operative surgery planning software market's services. Additionally, it has been predicted that the accessibility and availability of customized software in developing economies would stimulate new development opportunities.
The population of the Middle East is aging quickly, and as age is the primary risk factor for cancer, its incidence and prevalence are rising across all the people in the area. According to a 2012 World Bank research, 4.7% of the 336 million people living in the Middle East and Northern Africa (MENA) region are considered to be over the age of 65. This aging population places a heavy load on healthcare. The elderly population is more susceptible to illnesses that might be fatal and may need to be treated with surgery. As a result, the middle east region's growing population presents market expansion potential for surgical planning software.
The Brazil market dominated the LAMEA Surgical Planning Software Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,244.1 Thousands by 2028. The Argentina market is experiencing a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.6% during (2022 - 2028).
Based on Deployment, the market is segmented into Cloud and On-premise. Based on End Use, the market is segmented into Hospitals and Clinics & Others. Based on Application, the market is segmented into Orthopedic Surgery, Neurosurgery, Dental & Orthodontics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Materialise NV, Brainlab AG, 3D Systems Corporation, Renishaw Plc., Johnson & Johnson (DePuy Synthes), Canon, Inc. (Canon Medical Systems Corporation), and General Electric (GE) Co. (GE Healthcare).
Scope of the Study
Market Segments Covered in the Report:
By Deployment
- Cloud
- On-premise
By End Use
- Hospitals
- Clinics & Others
By Application
- Orthopedic Surgery
- Neurosurgery
- Dental & Orthodontics
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Stryker Corporation
- Zimmer Biomet Holdings, Inc
- Medtronic plc
- Materialise NV
- Brainlab AG
- 3D Systems Corporation
- Renishaw Plc
- Johnson & Johnson (DePuy Synthes)
- Canon, Inc. (Canon Medical Systems Corporation)
- General Electric (GE) Co. (GE Healthcare)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Surgical Planning Software Market, by Deployment
1.4.2 LAMEA Surgical Planning Software Market, by End Use
1.4.3 LAMEA Surgical Planning Software Market, by Application
1.4.4 LAMEA Surgical Planning Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019, Jan - 2022, Sep) Leading Players
Chapter 4. LAMEA Surgical Planning Software Market by Deployment
4.1 LAMEA Cloud Market by Country
4.2 LAMEA On-premise Market by Country
Chapter 5. LAMEA Surgical Planning Software Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinics & Others Market by Country
Chapter 6. LAMEA Surgical Planning Software Market by Application
6.1 LAMEA Orthopedic Surgery Market by Country
6.2 LAMEA Neurosurgery Market by Country
6.3 LAMEA Dental & Orthodontics Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Surgical Planning Software Market by Country
7.1 Brazil Surgical Planning Software Market
7.1.1 Brazil Surgical Planning Software Market by Deployment
7.1.2 Brazil Surgical Planning Software Market by End-use
7.1.3 Brazil Surgical Planning Software Market by Application
7.2 Argentina Surgical Planning Software Market
7.2.1 Argentina Surgical Planning Software Market by Deployment
7.2.2 Argentina Surgical Planning Software Market by End-use
7.2.3 Argentina Surgical Planning Software Market by Application
7.3 UAE Surgical Planning Software Market
7.3.1 UAE Surgical Planning Software Market by Deployment
7.3.2 UAE Surgical Planning Software Market by End-use
7.3.3 UAE Surgical Planning Software Market by Application
7.4 Saudi Arabia Surgical Planning Software Market
7.4.1 Saudi Arabia Surgical Planning Software Market by Deployment
7.4.2 Saudi Arabia Surgical Planning Software Market by End-use
7.4.3 Saudi Arabia Surgical Planning Software Market by Application
7.5 South Africa Surgical Planning Software Market
7.5.1 South Africa Surgical Planning Software Market by Deployment
7.5.2 South Africa Surgical Planning Software Market by End-use
7.5.3 South Africa Surgical Planning Software Market by Application
7.6 Nigeria Surgical Planning Software Market
7.6.1 Nigeria Surgical Planning Software Market by Deployment
7.6.2 Nigeria Surgical Planning Software Market by End-use
7.6.3 Nigeria Surgical Planning Software Market by Application
7.7 Rest of LAMEA Surgical Planning Software Market
7.7.1 Rest of LAMEA Surgical Planning Software Market by Deployment
7.7.2 Rest of LAMEA Surgical Planning Software Market by End-use
7.7.3 Rest of LAMEA Surgical Planning Software Market by Application
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 3D Systems Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Stryker Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 Zimmer Biomet Holdings, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Materialise NV
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 Johnson & Johnson (DePuy Synthes)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental &Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Renishaw PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Approvals and Trials:
8.9 Canon, Inc. (Canon Medical Systems Corporation)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Brainlab AG
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Companies Mentioned
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic plc
- Materialise NV
- Brainlab AG
- 3D Systems Corporation
- Renishaw Plc.
- Johnson & Johnson (DePuy Synthes)
- Canon, Inc. (Canon Medical Systems Corporation)
- General Electric (GE) Co. (GE Healthcare)
Methodology
LOADING...